Tom Rifai, MD, FACP, Henry Ford Health System, Regional Medical Director, Metabolic Health and Weight Management; Harvard Medical School, Online Lifestyle Medicine Course Director, Metabolic Syndrome talks...
He discusses the positioning of JAK inhibitors in the treatment of inflammatory bowel disease, which he presented at the virtual AIBD regional meeting July 25.
